👀📈 A $1.7M Insider Purchase of a Bank Stock
Plus a COO with 100% returns and a Director with 230% overall returns both made purchases
Hello!
This week we have 3 new insider stock trades:
🏦 A bank director just bought $1.7M of the stock
🏦 Another COO at a financial corp with 100% returns just bought more stock
🧪 A director at a biopharma company with 230% returns made a purchase
Top CEO Trades of the Week
Reminder: you can read about how CEO Watcher works and how we calculate returns and win rates here
Robert Plante - COO at PGC 0.00%↑ (link)
Another financial corporation whose stock has been killed over the past few months (down almost 40%). This is his first purchase since the 2020 crash in which he made killer returns.
Returns and Win Rate
Overall: 12% returns with a 100% win rate (3/3 trades)
1-year: 106% returns with a 100% win rate (3/3 trades)
90-day: 43% returns with a 100% win rate (3/3 trades)
Purchase Data (this week)
Total Amount Purchased: $39,899
Purchase Price: $26.60
Current Price: $25.11 (-5.6%)
Rating
Rating: 8
Why: I teetered between a 7 and an 8 here, but his returns, win rate, and the fact the stock is down significantly over the last few months and is below the price he paid pushed it up to an 8. The downsides are that the absolute amount of stock he bought is quite low (though it is his largest purchase) and he doesn’t have much history.
Joe Penland - Director at STEL 0.00%↑ (link)
He doesn’t have the greatest returns, but this is one of the largest purchases of the last week and I am always interested to see insiders at banks making big buys after the banking crash.
Returns and Win Rate
Overall: 14% returns with a 67% win rate (6/9 trades)
1-year: 25% returns with a 75% win rate (6/8 trades)
90-day: -5% returns with a 25% win rate (2/8 trades)
Purchase Data (this week)
Total Amount Purchased: $1,723,792
Purchase Price: $21.68
Current Price: $22.44 (+3.5%)
Rating
Rating: 7
Why: He doesn’t have good enough returns to get above a 7, but the stock is down over 35% in the last 6 months, this is his second time buying the dip, this is his largest purchase ever, and it’s one of the largest purchase out of any insiders this week.
Anthony Digiandomenico - Director at NDRA 0.00%↑ (link)
Killer name 👆. I tend to stay away from biotech companies because they are so insanely volatile, but this guy has killer historic returns, so I decided to include him.
Returns and Win Rate
Overall: 229% returns with a 71% win rate (17/24 trades)
1-year: 146% returns with a 100% win rate (24/24 trades)
90-day: 28% returns with a 62.5% win rate (15/24 trades)
Purchase Data (this week)
Total Amount Purchased: $100,000
Purchase Price: $1.20
Current Price: $1.68 (+40%)
Rating
Rating: 5
Why: He has insane one-year returns, but the stock is already 40% above what he paid and biotech is such a risky industry that I can’t go above a 5. This was also part of a public offering because they needed some cash after the stock is down 65% in the last year.